R & D projects aerospace and Health

The r & D projects are implemented for the creation or significant improvement in a production process, product or service. You Can also include industrial research and experimental development.

Summary sheet of the assistance

Action

Individual projects of r & D linked to the codicil to the HUGE and aerospace and Health.

Beneficiaries

Companies.

Call type

Continuous call.

Submission deadline

Applications may take on-line continuously until 31/12/2025.

Type of assistance

Help partially refundable.

Characteristics of the assitance

Fixed Euribor: 1 year.

The aid of up to 90 per cent of the approved budget.

The company shall provide at least 10 per cent of the budget with own resources.

The advance of up to 90 per cent of aid without requirement for additional guarantees.

Tranche non-reimbursable from 20 per cent of aid.

Redemption: 15 years including a lack of 2 years.

The CDTI may require the creation of security for the return of aid when the financial economic analysis of the company.

The CDTI may use a reduction or exemption of the required assurances.

Characteristics of the project

Minimum budget: €175,000 eligible

At least 12 months.

Projects can be concluded no later than 31/12/2026.

May include third-party funds

The funding mechanism for the recovery and resilience.

The actions financed must respect the principle not to cause significant harm the environment (principle DNSH).

Allows for generating motivated reports

YES

Gastos elegibles

All expenditure supported have been set aside exclusively or directly derived from the activity of r & D support.

They are eligible for aid staff costs; costs of equipment and material costs of contractual research, knowledge and patents, consultancy and services equivalent supplementary; overhead costs and other costs derived from the project. It is also eligible expenditure arising from the report of the auditor.

You can outsource specific activities of the project to other companies or research bodies.

The win may not be higher than 65 per cent of eligible budget in general,can reach up to 80 per cent for the biopharmaceutical industry.

Evaluation criteria

Criteriatechnical evaluation:

- Plan of commercial exploitation of the project.

- Technology and innovation of the project.

- The company in connection with the project.

Assessment of socio-economic impact, gender perspective, accessibility and sustainability.

Criteriafinancial evaluation:

- Analysis of the crisis.

- Analysis económico-financiero and venture capital.

- Analysis económico-financiero of the project.

- Adjustment of the company económico-financiera for his efforts in the project.

Incentive effect

The aid incentive effect if, before you start working in the project, the beneficiary has submitted a written request of CDTI aid.

Accumulation and incompatibilities of additional aid perception

Aid is incompatible with any other public aid at european level, state or autonomous community, with identical objectives and purpose.

Aid is incompatible with any private help whose source of funding comes from funds from the budget of the european Union (structural funds to the European Investment, or other).

Regulatory framework

This aid is governed by the european union regulation applicable national and european funds of the mechanism for the recovery and Resilience